{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:16:46Z","timestamp":1790295406434,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT 206331\/Z\/17\/Z"],"award-info":[{"award-number":["WT 206331\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126444","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T08:45:53Z","timestamp":1731228353000},"page":"126444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route"],"prefix":"10.1016","volume":"42","author":[{"given":"Marco Polo","family":"Peralta Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keya","family":"Downward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Satti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuailin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Sarfas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Redondo","family":"Azema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126444_bb0005","series-title":"Global Tuberculosis Report 2022","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126444_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.126444_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.126444_bb0020","first-page":"10","article-title":"100 years of BCG immunization: past, present, and future","author":"Tagliabue","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126444_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.778028","article-title":"A perspective on the success and failure of BCG","volume":"12","author":"Kumar","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0030","first-page":"698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis","volume":"271","author":"Colditz","year":"1994","journal-title":"Meta-Anal Published Literature Jama"},{"key":"10.1016\/j.vaccine.2024.126444_bb0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/iai.2.5.574-582.1970","article-title":"Aerosol-induced tuberculosis in subhuman Primates and the course of the disease after intravenous BCG vaccination","volume":"2","author":"Barclay","year":"1970","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/123.5.527","article-title":"Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey","volume":"123","author":"Ribi","year":"1971","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0045","first-page":"363","article-title":"Superiority of intravenously administered BCG and BCG cell walls in protecting rhesus monkeys (Macaca mulatta) against airborne tuberculosis","volume":"143","author":"Anacker","year":"1972","journal-title":"Z Immunitatsforsch Exp Klin Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0050","first-page":"351","article-title":"Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0055","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.192.10.1425","article-title":"Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex","volume":"192","author":"Gretz","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126444_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer\u2019s-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0065","first-page":"7","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","author":"Perdomo","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2024.126444_bb0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques","volume":"22","author":"White","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0075","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1038\/ncomms9533","article-title":"Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis","volume":"6","author":"Kaushal","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0080","first-page":"12","article-title":"Protective efficacy of inhaled BCG vaccination against ultra-low dose aerosol M. tuberculosis challenge in Rhesus macaques","author":"White","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2024.126444_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.126444_bb0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(24)00143-9","article-title":"Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial","volume":"24","author":"Satti","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2024.126444_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.126444_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.126444_bb0110","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126444_bb0115","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0120","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","article-title":"Robust IgM responses following intravenous vaccination with Bacille Calmette\u2013Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques","volume":"22","author":"Irvine","year":"2021","journal-title":"Nature immunology"},{"key":"10.1016\/j.vaccine.2024.126444_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41541-020-00263-7","article-title":"A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates","volume":"6","author":"Tanner","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.126444_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/368096","article-title":"Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guerin vaccination","volume":"187","author":"Brown","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0140","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"de Valli\u00e8re","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction","volume":"2014","author":"Chen","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0150","series-title":"Biological amplification systems in immunology","first-page":"85","article-title":"Opsonization","author":"Griffin","year":"1977"},{"key":"10.1016\/j.vaccine.2024.126444_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab\u2019) fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.191.2.287","article-title":"Inhibition of Ca2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome\u2013lysosome fusion and increased survival within human macrophages","volume":"191","author":"Malik","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126444_bb0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0170","article-title":"Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination","volume":"12","author":"Bitencourt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0175","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/nprot.2016.091","article-title":"Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry","volume":"11","author":"Moor","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2024.126444_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98176-5","article-title":"Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria","volume":"11","author":"Barr","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126444_bb0185","series-title":"Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages","author":"Manivannan","year":"2012"},{"key":"10.1016\/j.vaccine.2024.126444_bb0190","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41573-022-00501-8","article-title":"Avidity in antibody effector functions and biotherapeutic drug design","volume":"21","author":"Oostindie","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2024.126444_bb0195","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiac492","article-title":"Antibody avidity maturation following recovery from infection or the booster vaccination Grants breadth of SARS-CoV-2 neutralizing capacity","volume":"227","author":"Nakagama","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205102","article-title":"Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance","volume":"13","author":"Kimuda","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126444_bb0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41541-021-00337-0","article-title":"Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants","volume":"6","author":"Budroni","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.126444_bb0210","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126444_bb0215","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0220","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/IAI.70.2.584-590.2002","article-title":"Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine","volume":"70","author":"Vermont","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-64371-7_8","article-title":"Evolution and strain variation in BCG","volume":"1019","author":"Abdallah","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2024.126444_bb0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1574-6968.1992.tb05516.x","article-title":"Mycobacterium avium rough-to-smooth colony conversion resulting from growth in Tween 80 without presence of type-specific glycopeptidolipid antigens","volume":"98","author":"Wright","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2024.126444_bb0235","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1128\/IAI.69.9.5671-5678.2001","article-title":"Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo","volume":"69","author":"Schwebach","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126444_bb0240","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.chom.2023.05.006","article-title":"Airway T cells are a correlate of iv Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques","volume":"31","author":"Darrah","year":"2023","journal-title":"Cell Host Microbe"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:43:40Z","timestamp":1741887820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24011265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24011265"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126444","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126444"}}